Barclays’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.62M Buy
284,259
+135,584
+91% +$1.25M ﹤0.01% 2052
2025
Q1
$1.28M Sell
148,675
-128
-0.1% -$1.1K ﹤0.01% 2314
2024
Q4
$1.6M Sell
148,803
-6,376
-4% -$68.4K ﹤0.01% 2356
2024
Q3
$882K Buy
155,179
+64,101
+70% +$364K ﹤0.01% 2693
2024
Q2
$385K Sell
91,078
-21,174
-19% -$89.5K ﹤0.01% 2688
2024
Q1
$572K Sell
112,252
-98,178
-47% -$500K ﹤0.01% 2757
2023
Q4
$1.96M Buy
210,430
+49,853
+31% +$464K ﹤0.01% 2171
2023
Q3
$1.05M Sell
160,577
-31,574
-16% -$207K ﹤0.01% 2060
2023
Q2
$1.56M Buy
192,151
+2,538
+1% +$20.6K ﹤0.01% 1893
2023
Q1
$1.63M Buy
189,613
+179,613
+1,796% +$1.54M ﹤0.01% 1776
2022
Q4
$93K Sell
10,000
-179,290
-95% -$1.67M ﹤0.01% 3498
2022
Q3
$1.95M Buy
189,290
+179,290
+1,793% +$1.85M ﹤0.01% 1677
2022
Q2
$100K Sell
10,000
-109,911
-92% -$1.1M ﹤0.01% 3463
2022
Q1
$1.48M Sell
119,911
-72,443
-38% -$891K ﹤0.01% 2018
2021
Q4
$3.34M Buy
+192,354
New +$3.34M ﹤0.01% 1486
2021
Q3
Sell
-12,768
Closed -$292K 3952
2021
Q2
$292K Sell
12,768
-74,003
-85% -$1.69M ﹤0.01% 2727
2021
Q1
$1.3M Buy
86,771
+13,427
+18% +$201K ﹤0.01% 2151
2020
Q4
$396K Sell
73,344
-7,822
-10% -$42.2K ﹤0.01% 2425
2020
Q3
$369K Sell
81,166
-26,419
-25% -$120K ﹤0.01% 2448
2020
Q2
$529K Buy
107,585
+39,931
+59% +$196K ﹤0.01% 2297
2020
Q1
$214K Buy
67,654
+24,715
+58% +$78.2K ﹤0.01% 2511
2019
Q4
$111K Buy
42,939
+21,777
+103% +$56.3K ﹤0.01% 3418
2019
Q3
$67K Sell
21,162
-6,510
-24% -$20.6K ﹤0.01% 3586
2019
Q2
$93K Sell
27,672
-89,828
-76% -$302K ﹤0.01% 3625
2019
Q1
$358K Buy
+117,500
New +$358K ﹤0.01% 2770
2018
Q3
Sell
-57,030
Closed -$149K 4295
2018
Q2
$149K Buy
57,030
+48,850
+597% +$128K ﹤0.01% 2900
2018
Q1
$22K Sell
8,180
-13,927
-63% -$37.5K ﹤0.01% 3810
2017
Q4
$71K Sell
22,107
-1,047
-5% -$3.36K ﹤0.01% 3183
2017
Q3
$96K Buy
23,154
+21,328
+1,168% +$88.4K ﹤0.01% 2718
2017
Q2
$10K Sell
1,826
-12,454
-87% -$68.2K ﹤0.01% 3429
2017
Q1
$81K Buy
14,280
+13,731
+2,501% +$77.9K ﹤0.01% 2924
2016
Q4
$2K Buy
549
+242
+79% +$882 ﹤0.01% 3586
2016
Q3
$1K Buy
+307
New +$1K ﹤0.01% 3712